Home  >  Products  >  LOH11CR2A (von Willebrand factor A domain containing 5A) Blocking Peptide (the N terminal of LOH11CR2A)(100ug)
LOH11CR2A (von Willebrand factor A domain containing 5A) Blocking Peptide (the N terminal of LOH11CR2A)(100ug)

LOH11CR2A (von Willebrand factor A domain containing 5A) Blocking Peptide (the N terminal of LOH11CR2A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LOH11CR2A Antibody(ARP55093_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP55093
Size: 100ug
Weight: 86kDa
Gene: 4013
Format: Lyophilized powder
Target: LOH11CR2A may play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis.
Alternative names: BCSC-1; BCSC1
See Full Product Listings >